Cancer Institute A national cancer institute
designated cancer center
Profile http://med.stanford.edu/profiles/Katrin_Andreasson/ Email this profile Generate Profile PDF
Portrait View Larger

Katrin Andreasson

Academic Appointments

Key Documents

Contact Information

  • Academic Offices
    Alternate Contact
    Jackie Bautista Administrative Associate Tel Work 650 498 5855

Professional Overview

Honors and Awards

  • Pfizer/AFAR Innovations in Aging Research Award, American Federation for Aging Research (07/05)
  • Paul Beeson Physician Faculty Scholars in Aging Award, American Federation for Aging Research (07/2001)

Postdoctoral Advisees

Holden BrownPaul Larkin

Graduate & Fellowship Program Affiliations

Scientific Focus

Current Research Interests

We are interested in understanding the basic mechanisms by which neurons die in stroke and in neurodegenerative disease, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS). Our focus is on the cyclooxygenase-2 (COX-2) pathway, which has been found to play a critical role in promoting neuronal death in a number of models of neurological disease, including stroke, Parkinson’s disease, amyotrophic lateral sclerosis, and Alzheimer’s disease. We are examining the function of downstream prostaglandin receptor signaling pathways, focusing on the functions of prostaglandin receptors in glutamate toxicity, ischemia, and neuroinflammation. Using a combination of in vitro and in vivo genetic and pharmacological strategies, we are finding that specific prostaglandin receptor signaling pathways impact dramatically on disease progression in models of both acute and chronic neurodegeneration. The long-term goal of our research is to understand the contribution of prostaglandin signaling to neuronal injury in a wide array of neurological diseases and to develop therapeutic strategies targeting these pathways in human disease.

Publications

Publication tag cloud

Publication Topics

View All 40

Stanford Medicine Resources:

Footer Links: